Thursday, July 29, 2010

New Jersey will host Medical Marijuana Stakeholders Meeting

The Coalition for Medical Marijuana New Jersey CMMNJ

CONTACT: Ken Wolski or Chris Goldstein at 609 394 2137 or

New Jersey will host Medical Marijuana Stakeholders Meeting

The Coalition for Medical Marijuana New Jersey (CMMNJ) is proud to announce that on August 21, 2010 a Medical Marijuana Stakeholders Meeting will be held in conjunction with the national patient advocacy organization Americans for Safe Access (ASA).

This unique event will take place in Trenton, NJ at the New Jersey State Museum Auditorium on Saturday, August 21 from 10:00 AM until 4:00 PM.

Medical marijuana patients, their families, advocates, potential Alternative Treatment Center owners, and health care professionals should attend the meeting.

Steph Sherer, Executive Director of ASA, will be the featured presenter at the Stakeholders Meeting. Steph is an international leader and expert in medical cannabis advocacy who aids in drafting legislation and advises governments around the globe. She has been a guest lecturer at University of California, Berkeley and George Washington University, DC.

CMMNJ has worked with ASA as a resource throughout the medical marijuana legislative effort in New Jersey. Now that the Garden State has passed a compassionate use law it is vital for local advocates to learn from seasoned experts how to proceed forward. New Jersey’s medical cannabis patients and volunteers can also be an important part of the national discussion about safe access.

ASA has ambitious national, regional and local Goals and Objectives for providing medical marijuana to patients. The Stakeholders Meeting will look at the following topics:

1. Creating the political playing field necessary to pass federal, state, and local legislation.
2. Implementing medical cannabis laws with methods that meet the needs of patients.
3. Passing meaningful legislation that creates safe and legal access in additional states.

Jahan Marcu, a cannabinoid researcher from Temple University School of Medicine will present as Vice-Chair of ASA's Medical Advisory Board.

Also presenting on the status and details of New Jersey’s medical marijuana law will be CMMNJ’s Executive Director Ken Wolski RN and the group’s media spokesperson Chris Goldstein. Additional speakers will be announced.

The cost to attend the all-day conference is $20.

There is limited seating. To secure a place at this important meeting:
- Send a check made out to "CMMNJ" 219 Woodside Ave, Trenton, NJ 08618
- Or, pay through PayPal at make sure to put “Stakeholders Meeting” in the note

A benefit dinner with CMMNJ’s volunteers, Board members and ASA’s Steph Sherer will also take place on Friday night, 8/20/10 at 7:00 PM for $100.00. A separate payment is required for dinner reservations.

Media passes are available and a brief press conference will be held.

About ASA
Americans for Safe Access (ASA) is the largest national member-based organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research. ASA has over 30,000 active members with chapters and affiliates in more than 40 states. ASA protects the rights of cannabis patients.

Recent ASA Accomplishments:

Federal Policy on Medical Marijuana Turns Corner - Justice Department tells prosecutors to respect state law. The Justice Department told U.S. Attorneys that they should not expend resources prosecuting medical cannabis patients and their caregivers in states that have adopted laws allowing medical use.

ASA Works with US Rep. Sam Farr (D-CA)
to introduce the Truth In Trails Act, HR 3939, with 28 co-sponsors to allow medical defense in some federal marijuana trials by recognizing state medical cannabis laws.

Federal Agency Solicits Proposals for Cannabis Cultivation - Just seven months after the DEA again rejected a judge's recommendation that a university be granted a license to grow research cannabis, a federal "Request for Proposals" was issued for the production and distribution of cannabis.

Two Milestones reached by Dr. Sunil Aggarawal of the University of Washington, member of the ASA Medical & Scientific Advisory Board member:
- The American Medical Association affirmed the medical benefits of marijuana and urged further research, reversing its 72 year old position that marijuana be retained as a Schedule I substance with no medical value.
- Review of 79 clinical studies finds marijuana a safe, effective medicine - found that "nearly all of the 33 published controlled clinical trials conducted in the United States have shown significant and measurable benefits..."

CONTACT: Ken Wolski or Chris Goldstein at 609 394 2137

Americans for Safe Access online:

More about medical marijuana in New Jersey at

Read the full text of NJ's medical marijuana law

1 comment: